StemCell Institute Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 7096?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	70,000	0.683%
Individual Insiders	230,600	2.25%
Institutions	866,041	8.45%
General Public	1,695,713	16.5%
Public Companies	7,384,200	72.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 19 shareholders own 83.45% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
72.1%	Nihon Trim Co., Ltd.	7,384,200	JP¥10.4b	0%	no data
2.07%	Meiji Yasuda Asset Management Company Ltd.	212,200	JP¥298.6m	12.9%	0.13%
1.64%	Nagoya Small and Medium Business Investment & Consultation Co., Ltd.	168,000	JP¥236.4m	0%	1.55%
1.38%	Nikko Asset Management Co., Ltd.	141,500	JP¥199.1m	11.4%	no data
0.98%	Nomura Holdings Inc, Securities & Investment Arm	100,741	JP¥141.7m	0%	no data
0.88%	Kunimatsu Yamamoto	90,200	JP¥126.9m	0%	no data
0.83%	Masanori Mori	84,600	JP¥119.0m	0%	no data
0.77%	Resona Asset Management Co., Ltd.	79,200	JP¥111.4m	0%	0.01%
0.74%	Angel Japan Asset Management	76,000	JP¥106.9m	0%	0.17%
0.68%	Supercell Biotechnology Corporation	70,000	JP¥98.5m	0%	no data
0.61%	Mitsubishi UFJ Asset Management Co., Ltd.	62,600	JP¥88.1m	0%	no data
0.5%	Takafumi Shimizu	51,400	JP¥72.3m	0%	no data
0.12%	Simplex Asset Management Co., Ltd.	12,200	JP¥17.2m	0%	0.01%
0.088%	Dimensional Fund Advisors LP	9,000	JP¥12.7m	-0.23%	no data
0.039%	Kimihide Ando	4,000	JP¥5.6m	0%	no data
0.031%	Sumitomo Mitsui DS Asset Management Company, Limited	3,200	JP¥4.5m	0%	no data
0.013%	Amundi Asset Management SAS	1,300	JP¥1.8m	62.5%	no data
0.0039%	Tomoo Yamada	400	JP¥562.3k	0%	no data
0.00098%	Rakuten Investment Management, Inc.	100	JP¥141.3k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/10 09:08
End of Day Share Price	2025/01/10 00:00
Earnings	2024/09/30
Annual Earnings	2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

StemCell Institute Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Masatoshi Nagata	Ichiyoshi Research Institute Inc.
null null	Storm Research Limited